Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment

Van L. King, Robert K. Brooner, Michael S. Kidorf, Kenneth B. Stoller, Allan F. Mirsky

Research output: Contribution to journalArticlepeer-review

96 Scopus citations


Symptoms of DSM-IV attention-deficit hyperactivity disorder (ADHD) were determined in patients entering methadone maintenance treatment. The relationship of ADHD to psychiatric and substance abuse comorbidity, attention testing, and treatment outcome was analyzed; 19% of patients had a history of ADHD, and 88% of these had current symptoms. Continuous Performance Testing indicated poorer attention in patients with ADHD. The only substance use disorder more common in the ADHD group was clonidine. There was significantly more current axis I, dysthymic disorder, anxiety disorder (including social phobia), and antisocial personality disorder in the ADHD patients. There was no difference between groups at the 1-year follow-up for illicit drug use, treatment retention, or treatment performance. The ADHD diagnosis did not convey significant prognostic implications for methadone maintenance treatment. A strong psychiatric assessment and treatment focus in the treatment program may help to explain the good treatment outcome.

Original languageEnglish (US)
Pages (from-to)487-495
Number of pages9
JournalJournal of Nervous and Mental Disease
Issue number8
StatePublished - Aug 1999

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment'. Together they form a unique fingerprint.

Cite this